Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240,356,213
-
Total 13F shares
-
118,023,067
-
Share change
-
+6,861,822
-
Total reported value
-
$1,888,023,265
-
Put/Call ratio
-
66%
-
Price per share
-
$16.00
-
Number of holders
-
207
-
Value change
-
+$96,376,127
-
Number of buys
-
126
-
Number of sells
-
92
Institutional Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q2 2025
As of 30 Jun 2025,
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) was held by
207 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,023,067 shares.
The largest 10 holders included
True Wind Capital Management, L.P., AXON ENTERPRISE, INC., T. Rowe Price Investment Management, Inc., FMR LLC, Voss Capital, LP, MORGAN STANLEY, Clal Insurance Enterprises Holdings Ltd, Invesco Ltd., Pertento Partners LLP, and BlackRock, Inc..
This page lists
207
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.